Glewis, Sarah, Krishnasamy, Mei, Campbell, Ian, Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael, Lingaratnam, Senthil, Harris, Sam, Underhill, Craig, Georgiou, Chloe, Warren, Mark, Campbell, Robert, IJzerman, Maarten, Fagery, Mussab. Wiley-Blackwell; 2023. Patient and health care professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: a cross sectional survey..

Glewis, Sarah, Alexander, Marliese, Khabib, Muhammad N. H., Brennan, Annabelle, Lazarakis, Smaro, Martin, Jennifer, Tie, Jeane, Lingaratnam, Senthil, Michael, Michael. Nature Publishing Group; 2022. A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing.

Glewis, Sarah, Lingaratnam, Senthil, Krishnasamy, Michael, Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael. Sage; 2024. Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists.